114 related articles for article (PubMed ID: 21668303)
1. Use of mesenchymal stem cells as treatment for graft-versus-host disease: current knowledge and controversies.
Ortín M; Sierra J
Immunotherapy; 2011 Jun; 3(6):701-4. PubMed ID: 21668303
[No Abstract] [Full Text] [Related]
2. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cell therapy in skin: why and what for?
Khosrotehrani K
Exp Dermatol; 2013 May; 22(5):307-10. PubMed ID: 23614735
[TBL] [Abstract][Full Text] [Related]
4. A role for mesenchymal stem cells in the control of graft-versus-host disease.
Cohen JL; Sudres M
Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment.
Maziarz RT
Transfusion; 2016 Apr; 56(4):9S-14S. PubMed ID: 27079324
[No Abstract] [Full Text] [Related]
6. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles.
Fierabracci A; Del Fattore A; Luciano R; Muraca M; Teti A; Muraca M
Cell Transplant; 2015; 24(2):133-49. PubMed ID: 24268069
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
[TBL] [Abstract][Full Text] [Related]
8. Encapsulated mesenchymal stem cells for in vivo immunomodulation.
Zanotti L; Sarukhan A; Dander E; Castor M; Cibella J; Soldani C; Trovato AE; Ploia C; Luca G; Calvitti M; Mancuso F; Arato I; Golemac M; Jonjic N; Biondi A; Calafiore R; Locati M; D'Amico G; Viola A
Leukemia; 2013 Feb; 27(2):500-3. PubMed ID: 22878604
[No Abstract] [Full Text] [Related]
9. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells.
Keating A
Curr Opin Hematol; 2006 Nov; 13(6):419-25. PubMed ID: 17053453
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic applications of mesenchymal stromal cells.
Larsen S; Lewis ID
Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
[TBL] [Abstract][Full Text] [Related]
13. Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study.
Liu K; Chen Y; Zeng Y; Xu L; Liu D; Chen H; Zhang X; Han W; Wang Y; Zhao T; Wang J; Wang J; Han Q; Zhao C; Huang X
Stem Cells Dev; 2011 Oct; 20(10):1679-85. PubMed ID: 21142788
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.
Nasef A; Ashammakhi N; Fouillard L
Regen Med; 2008 Jul; 3(4):531-46. PubMed ID: 18588475
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells: biological properties and clinical applications.
García-Gómez I; Elvira G; Zapata AG; Lamana ML; Ramírez M; Castro JG; Arranz MG; Vicente A; Bueren J; García-Olmo D
Expert Opin Biol Ther; 2010 Oct; 10(10):1453-68. PubMed ID: 20831449
[TBL] [Abstract][Full Text] [Related]
16. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F
Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications].
Sellheyer K; Krahl D
Hautarzt; 2010 May; 61(5):429-34. PubMed ID: 20221573
[TBL] [Abstract][Full Text] [Related]
18. [Novel strategy for GVHD treatment: possible use of mesenchymal stem cells and interleukin-21].
Ozaki K
Rinsho Ketsueki; 2012 May; 53(5):483-6. PubMed ID: 22728548
[No Abstract] [Full Text] [Related]
19. Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes.
Sato K; Ozaki K; Mori M; Muroi K; Ozawa K
J Clin Exp Hematop; 2010; 50(2):79-89. PubMed ID: 21123965
[TBL] [Abstract][Full Text] [Related]
20. Stem-cell niche based comparative analysis of chemical and nano-mechanical material properties impacting ex vivo expansion and differentiation of hematopoietic and mesenchymal stem cells.
Jiang J; Papoutsakis ET
Adv Healthc Mater; 2013 Jan; 2(1):25-42. PubMed ID: 23184458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
